Condizione: As New. Unread book in perfect condition.
Condizione: New.
Condizione: New.
Condizione: As New. Unread book in perfect condition.
Condizione: As New. Unread book in perfect condition.
Condizione: New.
Editore: Merkur Rinteln; 1. Edition (29. Mai 2020), 2020
ISBN 10: 3812010348 ISBN 13: 9783812010344
Lingua: Tedesco
Da: Rarewaves.com USA, London, LONDO, Regno Unito
Prima edizione
EUR 42,52
Quantità: 6 disponibili
Aggiungi al carrelloPaperback. Condizione: New. 1.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 26,89
Quantità: 11 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 31,35
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 157 pages. German language. 8.19x0.39x11.57 inches. In Stock.
EUR 29,10
Quantità: 6 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 32,34
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. German language. 11.77x8.43x0.47 inches. In Stock.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 29,45
Quantità: 11 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 30,16
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 34,79
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. German language. 8.39x0.59x11.50 inches. In Stock.
EUR 32,02
Quantità: 6 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 38,94
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Brand New. German language. 8.27x0.24x11.69 inches. In Stock.
EUR 25,52
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Gut. 334 Seiten Exemplar aus einer wissenchaftlichen Bibliothek Sprache: Deutsch Gewicht in Gramm: 469 20,8 x 14,8 x 1,8 cm, Taschenbuch.
Editore: Berlin [u.a.] : Bosworth - London : Music Sales [Auslfg.]; Berlin [u.a.] : Bosworth - London : Music Sales [Auslfg.], 2014
ISBN 10: 3865438660 ISBN 13: 9783865438669
Lingua: Tedesco
Da: NEPO UG, Rüsselsheim am Main, Germania
EUR 25,99
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Neu. [Songbook]. Sprache: Deutsch Gewicht in Gramm: 969.
EUR 33,94
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 112,18
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 100,00
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Wie neu. New book, remains sealed. Language - English. Ships from Berlin.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 122,98
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: New. pp. 361.
EUR 158,36
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 158,35
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Editore: Springer US, Springer New York, 2015
ISBN 10: 1489999531 ISBN 13: 9781489999535
Lingua: Inglese
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 122,12
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The Reverse Transcriptase (RT) of Human Immunodeficiency Virus Type 1 (HIV-1) arguably ranks amongst one of the most extensively studied retroviral enzymes. Heterologous expression and purification of HIV-1 RT in the early eighties, approval of the first nucleoside analogue RT inhibitor (NRTI) in 1987, discovery of resistance to RT inhibitors, approval of the first non-nucleoside analogue RT inhibitor (NNRTI) in 1996 and the various crystal structures of RT with and without bound substrate(s) and/or inhibitors represent only a few of the important milestones that describe the a bench-to-bedside success in the continuing effort to combat HIV-1 infection and its consequences. Nucleoside and nonnucleoside RT inhibitors remain important components in frequently used drug regimens to treat the infection. RT inhibitors also play important roles in recently validated strategies to prevent transmission of the virus. The relevance of HIV-1 RT as a drug target has simultaneously triggered interest in basic research studies aimed at providing a more detailed understanding of interactions between proteins, nucleic acids, and small molecule ligands in general terms. In light of the ever-growing knowledge on structure and function of HIV-1 RT, this enzyme serves as a valuable 'model system' in efforts to develop novel experimental tools and to explain biochemical processes. This monograph is designed to provide an overview of important aspects in past and current HIV-1 RT research, with focus on mechanistic aspects and translation of knowledge into drug discovery and development. The first section includes chapters with emphasis placed on the coordination of the RT-associated DNA polymerase and ribonuclease H (RNase H) activities. The second covers mechanisms of action and future perspectives associated with NRTIs and NNRTIs, while the third section includes chapters focusing on novel strategies to target the RT enzyme. Chapters of the final part are intended to discussmechanisms involved in HIV variability and the development of drug resistance. We hope that these contributions will stimulate interest, and encourage research aimed at the development of novel RT inhibitors. The lack of bona fide RNase H inhibitors with potent antiviral activity provides an example for challenges and opportunities in the field.
EUR 204,39
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. pp. 372.
Condizione: New. pp. xiii + 622.
EUR 107,45
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 372 | Sprache: Englisch | Produktart: Bücher | The Reverse Transcriptase (RT) of Human Immunodeficiency Virus Type 1 (HIV-1) arguably ranks amongst one of the most extensively studied retroviral enzymes. Heterologous expression and purification of HIV-1 RT in the early eighties, approval of the first nucleoside analogue RT inhibitor (NRTI) in 1987, discovery of resistance to RT inhibitors, approval of the first non-nucleoside analogue RT inhibitor (NNRTI) in 1996 and the various crystal structures of RT with and without bound substrate(s) and/or inhibitors represent only a few of the important milestones that describe the a bench-to-bedside success in the continuing effort to combat HIV-1 infection and its consequences. Nucleoside and nonnucleoside RT inhibitors remain important components in frequently used drug regimens to treat the infection. RT inhibitors also play important roles in recently validated strategies to prevent transmission of the virus. The relevance of HIV-1 RT as a drug target has simultaneously triggered interest in basic research studies aimed at providing a more detailed understanding of interactions between proteins, nucleic acids, and small molecule ligands in general terms. In light of the ever-growing knowledge on structure and function of HIV-1 RT, this enzyme serves as a valuable ¿model system¿ in efforts to develop novel experimental tools and to explain biochemical processes. This monograph is designed to provide an overview of important aspects in past and current HIV-1 RT research, with focus on mechanistic aspects and translation of knowledge into drug discovery and development. The first section includes chapters with emphasis placed on the coordination of the RT-associated DNA polymerase and ribonuclease H (RNase H) activities. The second covers mechanisms of action and future perspectives associated with NRTIs and NNRTIs, while the third section includes chapters focusing on novel strategies to target the RT enzyme. Chapters of the final part are intended to discussmechanisms involved in HIV variability and the development of drug resistance. We hope that these contributions will stimulate interest, and encourage research aimed at the development of novel RT inhibitors. The lack of bona fide RNase H inhibitors with potent antiviral activity provides an example for challenges and opportunities in the field.